HomeDAWN • NASDAQ
add
Day One Biopharmaceuticals Inc
Previous close
$9.06
Day range
$8.24 - $9.26
Year range
$8.24 - $18.07
Market cap
831.98M USD
Avg Volume
1.03M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 29.21M | — |
Operating expense | 91.56M | 53.84% |
Net income | -65.71M | -20.55% |
Net profit margin | -224.99 | — |
Earnings per share | -0.63 | 1.56% |
EBITDA | -64.71M | -8.75% |
Effective tax rate | -10.93% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 531.72M | 45.14% |
Total assets | 582.79M | 54.98% |
Total liabilities | 80.04M | 171.24% |
Total equity | 502.75M | — |
Shares outstanding | 101.35M | — |
Price to book | 1.82 | — |
Return on assets | -27.60% | — |
Return on capital | -30.72% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -65.71M | -20.55% |
Cash from operations | -30.01M | 27.47% |
Cash from investing | -269.64M | -987.56% |
Cash from financing | 1.85M | 210.05% |
Net change in cash | -297.80M | -2,764.81% |
Free cash flow | -4.68M | 79.10% |
About
Founded
2018
Headquarters
Website
Employees
181
